Search Within

MALIGNANT MESOTHELIOMA
Results 1 - 34 of 34
Investigations of Malignant Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 12,Issue: 3
Page: 208-214
Authors: Jack A. Kastelik, Mahmoud Loubani, Gerard Avery, Anthony G. Arnold and Jaymin Morjaria

The Role of Systemic Treatment and Radiotherapy in Malignant Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 12,Issue: 3
Page: 232-240
Authors: Michael Lind, Rachael Barton, Andrzej Wieczorek, Mahmoud Loubani and Jack A. Kastelik

Epidemiology and Pathology of Malignant Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 12,Issue: 4
Page: 271-276
Authors: Jack A. Kastelik, Mahmoud Loubani, Michael Greenstone, Simon Hart and Anne Campbell

Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 7
Page: 631-641
Authors: M. R. Rippo, F. Villanova and A. Procopio

Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 1
Page: 19-26
Authors: S. Crispi, I. Cardillo, E. P. Spugnini, G. Citro, S. Menegozzo and A. Baldi

Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 3
Page: 476-482
Authors: Patroklos Katafygiotis, Constantinos Giaginis, Efstratios Patsouris and Stamatios Theocharis

Immune Checkpoints Aberrations and Malignant Mesothelioma: Assessment of Prognostic Value and Evaluation of Therapeutic Potentials

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 9
Page: 1228-1233
Authors: Hadeer Mohamed, Mostafa Eltobgy and Omar Abdel-Rahman*

Malignant Mesothelioma: Cell Survival Pathways and Radiation Therapy

Journal: Current Respiratory Medicine Reviews
Volume: 11,Issue: 3
Page: 189-196
Authors: Mutlay Sayan, H. James Wallace III, Ruth Heimann and Brooke T. Mossman

Molecular Targets and Targeted Therapies for Malignant Mesothelioma

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 9
Page: 855-867
Authors: Camilla Palumbo, Roberto Bei, Antonio Procopio and Andrea Modesti

Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches

Journal: Current Molecular Pharmacology
Volume: 2,Issue: 2
Page: 190-206
Authors: Marco Tomasetti, Monica Amati, Lory Santarelli, Renata Alleva and Jiri Neuzil

First Molecular Cytogenetic Characterization of Murine Malignant Mesothelioma Cell Line AE17 and In Silico Translation to the Human Genome

Journal: Current Bioinformatics
Volume: 12,Issue: 1
Page: 11-18
Authors: Eva Kubicova, Vladimir Trifonov, Fran Borovecki, Thomas Liehr, Martina Rincic, Nadezda Kosyakova and Shaymaa S. Hussein

Surgical Options for Management of Malignant Pleural Mesothelioma in the Current Era

Journal: Current Respiratory Medicine Reviews
Volume: 12,Issue: 4
Page: 286-293
Authors: Mahmoud Loubani, Syed S. Qadri, Azar Hussain, Mubarak A. Chaudhry and Jack A. Kastelik

Molecular Targets in Malignant Pleural Mesothelioma Treatment

Journal: Current Drug Targets
Volume: 10,Issue: 12
Page: 1235-1244
Authors: Giulia Pasello and Adolfo Favaretto

Improvement of malignant pleural mesothelioma immunotherapy by epigenetic modulators

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 7
Page: 777-787
Authors: Malik Hamaidia, Bernard Staumont, Bernard Duysinx, Renaud Louis and Luc Willems

The Role of microRNAs in the Diagnosis and Treatment of Malignant Pleural Mesothelioma - A Short Review

Journal: MicroRNA
Volume: 1,Issue: 1
Page: 40-48
Authors: Kelly W. Sheff, Mir A. Hoda, Balazs Dome, Balazs Hegedus, Walter Klepetko and Glen J. Weiss

Is α7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?

Journal: Current Drug Targets
Volume: 13,Issue: 5
Page: 688-694
Authors: Alfredo Cesario, Patrizia Russo, Candida Nastrucci and Pierluigi Granone

Malignant Pleural Mesothelioma in 2011. Is there a Gold Standard Therapy?

Journal: Current Respiratory Medicine Reviews
Volume: 8,Issue: 4
Page: 304-313
Authors: Steven C. Bharadwaj and Alexander S. Farivar

Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies

Journal: Current Drug Targets
Volume: 17,Issue: 7
Page: 824-849
Authors: Stefano Thellung, Roberto E. Favoni, Roberto Würth, Mario Nizzari, Alessandra Pattarozzi, Antonio Daga, Tullio Florio and Federica Barbieri

Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma

Journal: MicroRNA
Volume: 5,Issue: 1
Page: 12-18
Authors: Anna Truini, Simona Coco, Carlo Genova, Marco Mora, Maria G. Dal Bello, Irene Vanni, Angela Alama, Erika Rijavec, Giulia Barletta, Federica Biello, Claudia Maggioni and Francesco Grossi

Antibody-Onconase Conjugates: Cytotoxicity and Intracellular Routing

Journal: Current Pharmaceutical Biotechnology
Volume: 9,Issue: 3
Page: 226-230
Authors: S. M. Rybak

Ribonucleases and ImmunoRNases as Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 23
Page: 2665-2675
Authors: S. M. Rybak, M. A.E. Arndt, T. Schirrmann, S. Dubel and J. Krauss

Cox Inhibitors as Potential Chemotherapic Drugs for Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 3,Issue: 1
Page: 15-18
Authors: Enrico P. Spugnini, Gennaro Citro and Alfonso Baldi

Predictive Markers for Haematological Toxicity of Pemetrexed

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 48-57
Authors: S. C.H. Kao, V. H. Phan and S. J. Clarke

Will Antiangiogenic Agents be a Future for Mesothelioma Therapy?

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 27
Page: 3069-3079
Authors: C. Belli, S. Anand, M. Panella, M. Giovannini, G. Tassi, D. Fennell and L. Mutti

Synthesis and Antiproliferative Activity of Substituted 3[2-(1H-indol-3-yl)- 1,3-thiazol-4-yl]-1H-pyrrolo[3,2-b]pyridines, Marine Alkaloid Nortopsentin Analogues

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 14
Page: 1654-1666
Authors: A. Carbone, M. Pennati, P. Barraja, A. Montalbano, B. Parrino, V. Spano, A. Lopergolo, S. Sbarra, V. Doldi, N. Zaffaroni, G. Cirrincione and P. Diana

Evasion of Ribonuclease Inhibitor as a Determinant of Ribonuclease Cytotoxicity

Journal: Current Pharmaceutical Biotechnology
Volume: 9,Issue: 3
Page: 185-199
Authors: Thomas J. Rutkoski and Ronald T. Raines

Onconase and Amphinase, the Antitumor Ribonucleases from Rana pipiens Oocytes

Journal: Current Pharmaceutical Biotechnology
Volume: 9,Issue: 3
Page: 215-225
Authors: W. Ardelt, K. Shogen and Z. Darzynkiewicz

Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 2
Page: 101-109
Authors: Takayo Fukuda, Tomoko Tsuruga, Takako Kuroda, Hiroyuki Nishikawa and Tomohiko Ohta

Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells

Journal: Current Drug Targets
Volume: 15,Issue: 14
Page: 1331-1340
Authors: Leticia G. Leon, Maria Gemelli, Rocco Sciarrillo, Amir Avan, Niccola Funel and Elisa Giovannetti

Development of Novel Therapeutic Strategies for Lung Cancer: Targeting the Cholinergic System

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 29
Page: 3493-3512
Authors: P. Russo, A. Catassi, A. Cesario and D. Servent

Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 2
Page: 176-191
Authors: R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio and M. Casto

Dasatinib: An Anti-Tumour Agent via Src Inhibition

Journal: Current Drug Targets
Volume: 12,Issue: 4
Page: 563-578
Authors: Antonio Gnoni, Ilaria Marech, Nicola Silvestris, Angelo Vacca and Vito Lorusso

Role of the Non-Neuronal Human Cholinergic System in Lung Cancer and Mesothelioma: Possibility of New Therapeutic Strategies

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 4,Issue: 6
Page: 535-542
Authors: Sonya Trombino, Alessandra Bisio, Alessia Catassi, Alfredo Cesario, Carla Falugi and Patrizia Russo

Mesothelioma - Update on Management

Journal: Current Respiratory Medicine Reviews
Volume: 10,Issue: 4
Page: 206-220
Authors: Patricia Tai, Kurian Joseph, Avi Assouline, Joseph Au and Edward Yu

Results 1 - 34 of 34